tiprankstipranks
MDxHealth (MDXH)
NASDAQ:MDXH

MDxHealth (MDXH) Stock Forecast & Price Target

138 Followers
See the Price Targets and Ratings of:

MDXH Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
MDxHealth
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MDXH Stock 12 Month Forecast

There Are No Analyst Ratings for MDXH In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

MDXH Financial Forecast

MDXH Earnings Forecast

Next quarter’s earnings estimate for MDXH is -$0.27 with a range of -$0.29 to -$0.23. The previous quarter’s EPS was -$0.31. MDXH beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.28% of the time in the same period. In the last calendar year MDXH has Underperformed its overall industry.
Next quarter’s earnings estimate for MDXH is -$0.27 with a range of -$0.29 to -$0.23. The previous quarter’s EPS was -$0.31. MDXH beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.28% of the time in the same period. In the last calendar year MDXH has Underperformed its overall industry.

MDXH Sales Forecast

Next quarter’s sales forecast for MDXH is $20.73M with a range of $20.20M to $21.60M. The previous quarter’s sales results were $19.83M. MDXH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.64% of the time in the same period. In the last calendar year MDXH has Outperformed its overall industry.
Next quarter’s sales forecast for MDXH is $20.73M with a range of $20.20M to $21.60M. The previous quarter’s sales results were $19.83M. MDXH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.64% of the time in the same period. In the last calendar year MDXH has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BTIG
$8
Buy
243.35%
Upside
Reiterated
03/11/24
Analysts Conflicted on These Healthcare Names: MDxHealth (NASDAQ: MDXH), OrthoPediatrics (NASDAQ: KIDS) and Karuna Therapeutics (NASDAQ: KRTX)
TD Cowen
$6
Buy
157.51%
Upside
Assigned
03/07/24
Buy Rating Affirmed for MDxHealth Amid Strong Q4 Performance and Positive Future Outlook
Piper Sandler
$7
Buy
200.43%
Upside
Reiterated
03/07/24
Piper Sandler Sticks to Its Buy Rating for MDxHealth (MDXH)

Best Analysts Covering MDxHealth

Which Analyst Should I Follow If I Want to Buy MDXH and Sell After:
1 Month
Success Rate
0/1 ratings generated profit
0%
Average Return
-15.20%
reiterated a buy rating 4 months ago
Copying Mark Massaro's trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -15.20% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Success Rate
0/1 ratings generated profit
0%
Average Return
-6.40%
reiterated a buy rating 4 months ago
Copying Mark Massaro's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -6.40% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Success Rate
0/1 ratings generated profit
0%
Average Return
-26.20%
reiterated a buy rating 4 months ago
Copying Mark Massaro's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -26.20% per trade.
2 Years
Success Rate
0/1 ratings generated profit
0%
Average Return
-26.20%
reiterated a buy rating 4 months ago
Copying Mark Massaro's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -26.20% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MDXH Analyst Recommendation Trends

Rating
Mar 18
Apr 18
Jan 19
Jul 22
Mar 24
Strong Buy
0
0
0
1
5
Buy
5
9
8
4
0
Hold
0
0
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
9
9
6
6
In the current month, MDXH has received 5 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MDXH average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

MDXH Stock Forecast FAQ

What is MDXH’s average 12-month price target, according to analysts?
Currently, no data Available
What is MDXH’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MDXH, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is MDXH a Buy, Sell or Hold?
      Currently, no data Available
      What is MDxHealth’s price target?
      Currently, no data Available
      What do analysts say about MDxHealth?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of MDXH?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis